Abstract
Diaryl sulfides also known as diphenyl sulfides, phenylthiobenzylamines, and biphenylthiols are a class of compounds with phenylthiophenyl scaffold that have been validated as biomarkers to label the brain serotonin transporter (SERT), in vivo. The development of those synthetic and non-natural compounds started more than a decade ago when the observation that 5-chloro-((2-((dimethylamino)methyl)phenyl)thio)benzene-methanol hydrochloride also called 403U76 inhibited the serotonin and norepinephrine uptake into rat brain synaptosomes, led to the preparation of few derivatives based on 403U76 chemical structure. The new class of compounds, called the diaryl sulfide family, was investigated as biomarkers for the brain SERT. The promising data demonstrated by the carbon-11 labeled diaryl sulfides led to the translation of few of them into humans and the further evaluation of the phenylthiophenyl core structure by developing some fluorinated derivatives. This review will mainly focus on the fluorinated diaryl sulfides as fluorine-containing tracers validated to image the human brain SERT using positron emission tomography.
Keywords: Biphenylthiols, Diaryl Sulfides, Diphenyl Sulfides, Fluorine-18, Phenylthiobenzylamines, Serotonin Transporter.
Current Topics in Medicinal Chemistry
Title:Fluorinated Diaryl Sulfides
Volume: 13 Issue: 8
Author(s): Nashwa Jarkas
Affiliation:
Keywords: Biphenylthiols, Diaryl Sulfides, Diphenyl Sulfides, Fluorine-18, Phenylthiobenzylamines, Serotonin Transporter.
Abstract: Diaryl sulfides also known as diphenyl sulfides, phenylthiobenzylamines, and biphenylthiols are a class of compounds with phenylthiophenyl scaffold that have been validated as biomarkers to label the brain serotonin transporter (SERT), in vivo. The development of those synthetic and non-natural compounds started more than a decade ago when the observation that 5-chloro-((2-((dimethylamino)methyl)phenyl)thio)benzene-methanol hydrochloride also called 403U76 inhibited the serotonin and norepinephrine uptake into rat brain synaptosomes, led to the preparation of few derivatives based on 403U76 chemical structure. The new class of compounds, called the diaryl sulfide family, was investigated as biomarkers for the brain SERT. The promising data demonstrated by the carbon-11 labeled diaryl sulfides led to the translation of few of them into humans and the further evaluation of the phenylthiophenyl core structure by developing some fluorinated derivatives. This review will mainly focus on the fluorinated diaryl sulfides as fluorine-containing tracers validated to image the human brain SERT using positron emission tomography.
Export Options
About this article
Cite this article as:
Jarkas Nashwa, Fluorinated Diaryl Sulfides, Current Topics in Medicinal Chemistry 2013; 13 (8) . https://dx.doi.org/10.2174/1568026611313080006
DOI https://dx.doi.org/10.2174/1568026611313080006 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Synthesis and Biological Evaluation of 2´-Hydroxy-4´,6´-Diprenyloxychal-Cone Derivatives as Potent CDC25B and PTP1B Inhibitors
Letters in Drug Design & Discovery Curcumin Efficacy in a Serum/Glucose Deprivation-Induced Neuronal PC12 Injury Model
Current Molecular Pharmacology Molecular Basis of Familial and Sporadic Alzheimer's Disease
Current Alzheimer Research Hemostatic Factors and the Metabolic Syndrome
Current Vascular Pharmacology Addressing Alzheimer’s Disease and Cognitive Loss through Autophagy
Current Neurovascular Research MicroRNAs as Therapeutic Agents: The Future of the Battle Against Cancer
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Common Environmental Factors May Underpin the Comorbidity Between Generalized Anxiety Disorder and Mood Disorders Via Activated Nitrooxidative Pathways
Current Topics in Medicinal Chemistry A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines
Current Pharmaceutical Design Supervised Disulfiram as Adjunct to Psychotherapy in Alcoholism Treatment
Current Pharmaceutical Design Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry Mechanisms of Action of Imidazoacridinone and Triazoloacridinone Derivatives in View of their Biological Activity
Current Pharmaceutical Analysis Assessment of Physical Health Status, Depression and Activities of Daily Living Among Chronic Obstructive Pulmonary Disease Patients in Tertiary Care Hospitals in Mangalore, India
Current Respiratory Medicine Reviews Endomorphin Derivatives with Improved Pharmacological Properties
Current Medicinal Chemistry Non-Pharmacological Interventions to Improve Health Status in COPD
Current Respiratory Medicine Reviews Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology Clinical Analysis Methods of Voice Disorders
Current Bioinformatics Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials Forceps: Still an Option?
Current Women`s Health Reviews